Quantcast
Last updated on April 17, 2014 at 16:25 EDT

Latest Diagnostic test Stories

2013-03-12 04:21:19

NEWCASTLE-UPON-TYNE, England, March 12, 2013 /PRNewswire/ -- - Leica Biosystems and Synthon Biopharmaceuticals announce partnership to develop a companion diagnostic test for solid tumors - Leica Biosystems will develop a fully automated tissue-based companion diagnostic test to run on the BOND(TM)automated advanced staining systems - Synthon strengthens its innovative drug pipeline with the development of a companion...

2013-02-26 12:28:37

TUCSON, Ariz., Feb. 26, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and Biocare Medical, LLC (Biocare) today announced that they have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx Medical, Inc. (AsymmetRx) have settled their dispute as it relates to the p63 technology. As part of the...

2013-01-25 10:14:31

Mobile device can easily be used in remote areas around the world Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has taken his innovative lab-on-a-chip and developed a way to not only check a patient's HIV status anywhere in the world with just a finger prick, but also synchronize the results automatically and instantaneously with central health-care records–10 times faster, the researchers say, than the benchtop ELISA, a broadly used diagnostic...

2013-01-07 16:25:29

MADISON, N.J., Jan. 7, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2012 results and provide financial guidance for 2013 on Wednesday, January 23, 2013 before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in...

2012-11-09 08:28:29

BOULDER, Colo. and MELLRICHSTADT, Germany, Nov. 9, 2012 /PRNewswire/ -- Boulder Diagnostics Inc. announced today the European market launch of the CE marked SpiroFind in vitro diagnostic test for the detection of active Lyme Borreliosis. The SpiroFind test is offered as a diagnostic service by the company's clinical diagnostic service laboratory in Mellrichstadt, Germany. The novel SpiroFind test can detect active Lyme Borreliosis through all stages of disease from early disease to late and...

2012-08-24 06:23:06

MADISON, N.J., Aug. 24, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, accepted a 2012 CIO 100 award from International Data Group's (IDG) CIO magazine for its Gazelle® mobile health application. The 25th annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology. The Gazelle mobile application for...

2012-06-14 06:24:05

Survey Shows High Awareness and Potential for Rapid Adoption QUEBEC CITY, June 14, 2012 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR), a Quebec life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced that LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, has published an independent survey of 273 practicing urologists who answered within two days on their...

2012-01-17 10:07:38

TV crime shows like Bones and CSI are quick to explain each death by showing highly detailed scans and video images of victims' insides. Traditional autopsies, if shown at all, are at best in supporting roles to the high-tech equipment, and usually gloss over the sometimes physically grueling tasks of sawing through skin and bone. But according to two autopsy and body imaging experts at The Johns Hopkins Hospital, the notion that "virtopsy" could replace traditional autopsy-- made popular...

2011-08-10 18:15:52

Press release from PLoS Medicine Despite being widely available for sale in low-and-middle income countries, commercial serological tests used to detect active tuberculosis (by identifying antibodies to the tuberculosis-causing bacterium in a blood sample) do not accurately diagnose TB and, furthermore, often test positive when the patient does not have TB (false positive) and test negative when the patient actually has TB (false negative). In addition, as shown in India, the use of such...

2011-08-10 11:30:00

SAN DIEGO, Aug. 10, 2011 /PRNewswire/ -- TrovaGene, Inc. (Pink Sheets: TROV.PK), a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc. (NASDAQ: SQNM). In 2008, TrovaGene licensed several of its patents to Sequenom for the development of...